These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
487 related articles for article (PubMed ID: 36563642)
1. Cancer/testis antigen HEMGN correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma. Jiang Y; Yu L; Hu Q; Kang Y; You J; Huang C; Xu X; Chen L Mol Immunol; 2023 Jan; 153():226-237. PubMed ID: 36563642 [TBL] [Abstract][Full Text] [Related]
2. Cancer-testis antigen KK-LC-1 is a potential biomarker associated with immune cell infiltration in lung adenocarcinoma. Kang Y; Gan Y; Jiang Y; You J; Huang C; Chen Q; Xu X; Chen F; Chen L BMC Cancer; 2022 Jul; 22(1):834. PubMed ID: 35907786 [TBL] [Abstract][Full Text] [Related]
3. Down-regulation of interleukin-2 predicts poor prognosis and associated with immune escape in lung adenocarcinoma. Hou Y; Xiang B; Yang Z; Liu J; Xu D; Geng L; Zhan M; Xu Y; Zhang B Int J Immunopathol Pharmacol; 2023; 37():3946320231202748. PubMed ID: 37731383 [No Abstract] [Full Text] [Related]
4. ECE2 is a prognostic biomarker associated with m6A modification and involved in immune infiltration of lung adenocarcinoma. Zhang YH; Zeng J; Liu XS; Gao Y; Kui XY; Liu XY; Zhang Y; Pei ZJ Front Endocrinol (Lausanne); 2022; 13():1013238. PubMed ID: 36299451 [TBL] [Abstract][Full Text] [Related]
5. The EMT-Related Genes GALNT3 and OAS1 are Associated with Immune Cell Infiltration and Poor Prognosis in Lung Adenocarcinoma. Luo D; Fang M; Shao L; Wang J; Liang Y; Chen M; Gui X; Yan J; Wang W; Yu L; Fan X; Wu Q Front Biosci (Landmark Ed); 2023 Oct; 28(10):271. PubMed ID: 37919050 [TBL] [Abstract][Full Text] [Related]
6. Study of LY9 as a potential biomarker for prognosis and prediction of immunotherapy efficacy in lung adenocarcinoma. Deng K; Yuan L; Xu Z; Qin F; Zheng Z; Huang L; Jiang W; Qin J; Sun Y; Zheng T; Ou X; Zheng L; Li S PeerJ; 2024; 12():e17816. PubMed ID: 39193519 [TBL] [Abstract][Full Text] [Related]
7. Protein phosphatase 1 regulatory subunit 3G (PPP1R3G) correlates with poor prognosis and immune infiltration in lung adenocarcinoma. Zhuo X; Chen L; Lai Z; Liu J; Li S; Hu A; Lin Y Bioengineered; 2021 Dec; 12(1):8336-8346. PubMed ID: 34592886 [TBL] [Abstract][Full Text] [Related]
8. Decreased expression of JAK1 associated with immune infiltration and poor prognosis in lung adenocarcinoma. Cai J; Deng H; Luo L; You L; Liao H; Zheng Y Aging (Albany NY); 2020 Dec; 13(2):2073-2088. PubMed ID: 33323549 [TBL] [Abstract][Full Text] [Related]
9. Bioinformatic Analysis Reveals Bone Marrow Kinase as a Potential Diagnostic and Prognostic Biomarker for Multiple Cancer Types. Khalafallah SA; Eltayeb Ahmed EA; Elnour LS; Mohammed R; Makawi A; Mohamed AK; Balla A; Alamin MF; Alfaki M Cureus; 2024 Aug; 16(8):e68093. PubMed ID: 39347140 [TBL] [Abstract][Full Text] [Related]
10. DPYSL2 as potential diagnostic and prognostic biomarker linked to immune infiltration in lung adenocarcinoma. Wu YJ; Nai AT; He GC; Xiao F; Li ZM; Tang SY; Liu YP; Ai XH World J Surg Oncol; 2021 Sep; 19(1):274. PubMed ID: 34517904 [TBL] [Abstract][Full Text] [Related]
11. Prognostic biomarker TUBA1C is correlated to immune cell infiltration in the tumor microenvironment of lung adenocarcinoma. Bian T; Zheng M; Jiang D; Liu J; Sun H; Li X; Liu L; Zhang J; Liu Y Cancer Cell Int; 2021 Mar; 21(1):144. PubMed ID: 33653340 [TBL] [Abstract][Full Text] [Related]
12. Cancer testis antigen MAGEA3 in serum and serum-derived exosomes serves as a promising biomarker in lung adenocarcinoma. Gan Y; Kang Y; Zhong R; You J; Chen J; Li L; Chen J; Chen L Sci Rep; 2024 Mar; 14(1):7573. PubMed ID: 38555374 [TBL] [Abstract][Full Text] [Related]
13. Identification of Bian T; Zhang W; Wang F; Chu X; Pan X; Ruan J; Yu S; Liu L; Sun H; Qiu H; Li Y; Tang J; Zhao X; Zhang H Comb Chem High Throughput Screen; 2023; 26(14):2452-2468. PubMed ID: 37038295 [TBL] [Abstract][Full Text] [Related]
14. NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis. Liu XS; Zhou LM; Yuan LL; Gao Y; Kui XY; Liu XY; Pei ZJ Front Immunol; 2021; 12():724741. PubMed ID: 34335635 [TBL] [Abstract][Full Text] [Related]
15. HMMR associates with immune infiltrates and acts as a prognostic biomaker in lung adenocarcinoma. Ma X; Xie M; Xue Z; Yao J; Wang Y; Xue X; Wang J Comput Biol Med; 2022 Dec; 151(Pt A):106213. PubMed ID: 36306573 [TBL] [Abstract][Full Text] [Related]
16. TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma. Guo L; Li X; Liu R; Chen Y; Ren C; Du S Cancer Med; 2020 Sep; 9(18):6694-6709. PubMed ID: 32700817 [TBL] [Abstract][Full Text] [Related]
17. Zhang XZ; Chen MJ; Fan PM; Jiang W; Liang SX Int J Gen Med; 2022; 15():2727-2745. PubMed ID: 35300128 [TBL] [Abstract][Full Text] [Related]
18. TMPRSS2 Serves as a Prognostic Biomarker and Correlated With Immune Infiltrates in Breast Invasive Cancer and Lung Adenocarcinoma. Xiao X; Shan H; Niu Y; Wang P; Li D; Zhang Y; Wang J; Wu Y; Jiang H Front Mol Biosci; 2022; 9():647826. PubMed ID: 35558557 [TBL] [Abstract][Full Text] [Related]
19. EZH2 as a prognostic-related biomarker in lung adenocarcinoma correlating with cell cycle and immune infiltrates. Fan K; Zhang BH; Han D; Sun YC BMC Bioinformatics; 2023 Apr; 24(1):149. PubMed ID: 37069494 [TBL] [Abstract][Full Text] [Related]
20. KIAA1199 Correlates With Tumor Microenvironment and Immune Infiltration in Lung Adenocarcinoma as a Potential Prognostic Biomarker. Shen X; Mo X; Tan W; Mo X; Li L; Yu F; He J; Deng Z; Xing S; Chen Z; Yang J Pathol Oncol Res; 2022; 28():1610754. PubMed ID: 36419650 [No Abstract] [Full Text] [Related] [Next] [New Search]